While the transgenic human TREM2 leads to the high expression of TREM2 at the early stage of mice development, the expression of endogenous TREM2 was only found to be elevated at the later stage of disease.227 This may explain why the overexpressed TREM2 found in AD patients didn’t prevent disease progression. This evidence concerns the gene TREM2 and Alzheimer disease.